NCI Director Announces Personal Cancer Diagnosis
Statement from ACS and ACS CAN CEO Karen E. Knudsen on the announcement NCI Director Monica Bertagnolli has been diagnosed with breast cancer.
Statement from ACS and ACS CAN CEO Karen E. Knudsen on the announcement NCI Director Monica Bertagnolli has been diagnosed with breast cancer.
The following was originally published in the Empire Report on December 6, 2022.
Washington, D.C.— Patient groups representing millions of people with serious health conditions submitted an amicus brief today urging the U.S.
Today U.S. District Court Judge Reed O’Connor issued a ruling that may lead Affordable Care Act-compliant health plans to deny coverage for or reinstate cost-sharing for certain preventive health services.
Today, the New Jersey legislature passed the state’s operating budget. Included in that budget was an increase of $1.5 million in funding for the New Jersey Cancer Education and Early Detection (NJCEED) program for a total of $5 million.
TALLAHASSEE, FL – June 2, 2022 – Today, Gov.
LANSING, MICH. – After two years of virtual Cancer Action Days due to the pandemic, cancer patients, survivors and caregivers from across the state traveled to the Capitol in Lansing yesterday to meet in person with their elected officials.
Cancer patients, survivors and advocates from across the state gathered at the State Capitol on Wednesday to press lawmakers to address several critical issues affecting access to health care for tens of thousands of Kansans, particularly those in need of cancer screening and treatment. The meetings were part of Kansas Cancer Action Day, an annual event organized by the American Cancer Society Cancer Action Network (ACS CAN) to make fighting cancer a legislative prioritity.
American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Arizona rallied at the State Capitol Monday to urge lawmakers to pass legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing is critical in accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients.
TALLAHASSEE, FL – March 11, 2022 – The Florida House and Senate finalized the 2022 budget late yesterday, including failing to fully fund the state’s Mary Brogan Breast and Cervical Cancer Early Detection program.